T. Rowe Price Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15B | Buy |
|
|||||
|
2025
Q1 | $1.04B | Buy |
|
|||||
|
2024
Q4 | $600M | Buy |
|
|||||
|
2024
Q3 | $736M | Buy |
|
|||||
|
2024
Q2 | $605M | Sell |
|
|||||
|
2024
Q1 | $853M | Buy |
|
|||||
|
2023
Q4 | $844M | Sell |
|
|||||
|
2023
Q3 | $748M | Buy |
|
|||||
|
2023
Q2 | $675M | Buy |
|
|||||
|
2023
Q1 | $662M | Sell |
|
|||||
|
2022
Q4 | $989M | Buy |
|
|||||
|
2022
Q3 | $916M | Sell |
|
|||||
|
2022
Q2 | $909M | Sell |
|
|||||
|
2022
Q1 | $1.03B | Sell |
|
|||||
|
2021
Q4 | $1.08B | Sell |
|
|||||
|
2021
Q3 | $902M | Sell |
|
|||||
|
2021
Q2 | $1.08B | Buy |
|
|||||
|
2021
Q1 | $905M | Sell |
|
|||||
|
2020
Q4 | $950M | Sell |
|
|||||
|
2020
Q3 | $1.01B | Sell |
|
|||||
|
2020
Q2 | $1.38B | Buy |
|
|||||
|
2020
Q1 | $1.15B | Buy |
|
|||||
|
2019
Q4 | $1.42B | Sell |
|
|||||
|
2019
Q3 | $1.21B | Buy |
|
|||||
|
2019
Q2 | $1.02B | Sell |
|
|||||
|
2019
Q1 | $1.33B | Buy |
|
|||||
|
2018
Q4 | $1.51B | Buy |
|
|||||
|
2018
Q3 | $1.66B | Sell |
|
|||||
|
2018
Q2 | $1.51B | Buy |
|
|||||
|
2018
Q1 | $1.29B | Buy |
|
|||||
|
2017
Q4 | $1.09B | Buy |
|
|||||
|
2017
Q3 | $713M | Buy |
|
|||||
|
2017
Q2 | $668M | Buy |
|
|||||
|
2017
Q1 | $575M | Sell |
|
|||||
|
2016
Q4 | $595M | Sell |
|
|||||
|
2016
Q3 | $1.28B | Buy |
|
|||||
|
2016
Q2 | $929M | Sell |
|
|||||
|
2016
Q1 | $1.75B | Sell |
|
|||||
|
2015
Q4 | $1.82B | Sell |
|
|||||
|
2015
Q3 | $2.12B | Buy |
|
|||||
|
2015
Q2 | $2.11B | Buy |
|
|||||
|
2015
Q1 | $1.9B | Sell |
|
|||||
|
2014
Q4 | $1.82B | Sell |
|
|||||
|
2014
Q3 | $1.67B | Buy |
|
|||||
|
2014
Q2 | $1.54B | Buy |
|
|||||
|
2014
Q1 | $1.34B | Buy |
|
|||||
|
2013
Q4 | $1.15B | Buy |
|
|||||
|
2013
Q3 | $906M | Sell |
|
|||||
|
2013
Q2 | $933M | Buy |
|